For 30 years, metastatic urothelial carcinoma was a therapeutic dead end. Platinum-based chemotherapy remained the first-line ...

With the subcutaneous (SC) version of MSD’s (known as Merck & Co. in the U.S. and Canada) blockbuster Keytruda (pembrolizumab ...

Astellas Korea highlighted the clinical impact of its antibody-drug conjugate (ADC) Padcev (ingredient: enfortumab vedotin) ...

The results of the first quarter of this year's pharmaceutical industry business management analysis showed that ...

Korea's GC Biopharma has signed a strategic memorandum of understanding (MOU) with the Thai Red Cross Society to collaborate ...

The family of a patient with stage 4 lung cancer recently launched a petition on the National Assembly's platform, pleading ...

Calls are growing to expand health insurance coverage for the HER2-positive breast cancer treatment Enhertu (trastuzumab deruxtecan) to include HER2-low breast cancer.The Health Insurance Review and A ...

CG MedTech, a Korean orthopedic implant research and manufacturing company, posted strong first-half results in 2025 on the ...

A 20-year follow-up study has shown that eradication of Helicobacter pylori is effective in preventing osteoporosis in women ...

Dx&Vx said its subsidiary Avixgen has signed a global licensing agreement worth about 500 billion won ($360.3 million) with a ...

A study has found that high-dose use of inhaled corticosteroids may increase the risk of developing idiopathic pulmonary ...

Leqembi (lecanemab), developed for Alzheimer's disease, the most common form of dementia, is often hailed as a “dream ...